Synthyroxine

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Synthyroxine

What is Synthyroxine?

Synthyroxine is a synthetic pharmaceutical preparation of the thyroid hormone thyroxine. It is designed to be chemically identical to the endogenous hormone naturally produced and secreted by the human thyroid gland.

Primary Function

The primary role of Synthyroxine is to act as a hormone replacement. In the body, thyroxine is essential for the regulation of metabolic processes, energy production, and the maintenance of various organ functions. When the thyroid gland does not produce sufficient levels of this hormone, synthetic thyroxine is used to restore hormonal balance.

Mechanism of Action

Once administered, Synthyroxine functions as a prohormone. It circulates in the bloodstream and is converted by various tissues into triiodothyronine, which is the more active form of the hormone. This conversion allows the body to maintain stable levels of thyroid activity, affecting almost every physiological process, including:

  • Metabolic Rate: Influencing how the body uses energy and oxygen.
  • Body Temperature: Assisting in the regulation of internal heat production.
  • Growth and Development: Supporting normal physical and neurological growth, particularly in developing systems.

Composition

As a synthetic version of the T4 hormone, Synthyroxine is formulated to provide a consistent and predictable dose. This stability is intended to allow for precise management of hormone levels over a long-term period, ensuring that physiological requirements are met when natural production is inadequate.

Regulatory References

  1. Levothyroxine: MedlinePlus Drug Information
  2. Levothyroxine Sodium Label

What side effects are possible with Synthyroxine?

Possible Side Effects and Safety Information

The safety profile of Synthyroxine (Levothyroxine Sodium) is closely tied to its hormonal function, as adverse reactions primarily reflect the physiological signs of hyperthyroidism (hormone excess) resulting from a dose exceeding the patient's replacement needs. For this reason, the frequency of adverse effects at the correct, individualized replacement dose is often classified in regulatory documents as 'Not known'.

Officially documented adverse reactions are grouped into standard System-Organ Classes (SOCs). The most commonly affected systems noted in regulatory labeling include Cardiac disorders (e.g., palpitations, tachycardia, increased blood pressure), Nervous system disorders (e.g., headache, tremor), Psychiatric disorders (e.g., insomnia, restlessness), and Metabolism and nutrition disorders (e.g., weight loss, heat intolerance).

Serious Safety Considerations

The official labeling highlights the risk of serious cardiac events, particularly in vulnerable patients. These documented serious adverse reactions include the exacerbation of existing Angina Pectoris, development of new Cardiac Arrhythmias (such as Atrial Fibrillation), and the risk of Myocardial Infarction, especially in older adults or those with pre-existing heart disease. Safety is also formally constrained by absolute contraindications in specific conditions, such as untreated hyperthyroidism and uncorrected adrenal insufficiency.

Safety Patterns and Special Populations

Adverse effects demonstrate a time-related pattern, being more likely to occur at the start of treatment and during dose escalation before the optimal hormone level is achieved. Furthermore, the regulatory profile includes specific safety notes for special populations, mandating extreme caution and lower initial doses for older adults and patients with underlying Cardiovascular disease due to their heightened cardiac risk.

Overdose and Emergency Response

Overdose with Synthyroxine (Levothyroxine Sodium) is officially documented to produce clinical signs and symptoms consistent with thyrotoxicosis (hyperthyroidism). These documented manifestations reflect the effects of excessive circulating thyroid hormone on physiological systems.

Documented Manifestations

Symptoms commonly listed in regulatory labeling include tachycardia, palpitations, and increased blood pressure, alongside nervous system effects such as tremors, nervousness, anxiety, and insomnia. Other documented manifestations are heat intolerance, fever, fatigue, and unexplained weight loss.

Serious Outcomes and When to Seek Help

Larger doses may result in serious or life-threatening manifestations of toxicity. The most critical outcomes documented in official sources include myocardial ischemia, myocardial infarction, cardiac arrest, and death. The risk of these severe cardiac events is officially noted to be increased in elderly patients and individuals with pre-existing cardiovascular disease.

Immediate medical attention must be sought if serious or life-threatening manifestations of toxicity are suspected. Management is officially described as symptomatic and supportive, addressing the specific clinical presentation, as no specific antidote is known or listed in regulatory prescribing information.

Therapeutic Uses of Synthyroxine

Quick Facts

  • Main Use: Replacement therapy for underactive thyroid function (hypothyroidism).
  • Therapeutic Action: May help restore normal thyroid hormone levels.
  • Other Role: Used to manage specific types of thyroid cancer in an adjuvant setting.

Synthyroxine is a prescription medication utilized as a replacement therapy for adults and children diagnosed with hypothyroidism. This condition occurs when the body does not produce a sufficient amount of the thyroid hormone needed to support the body's metabolic functions.

Therapy with Synthyroxine is intended to help restore adequate hormone levels, which may assist in the alleviation of symptoms associated with primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is a fundamental component of treatment to achieve and maintain a hormonally balanced state (euthyroid status).

Additionally, the medication is employed as an adjunct to other therapies, such as surgery and radioiodine, for the management of thyrotropin-dependent well-differentiated thyroid cancer. Patients should consult their healthcare professional for full medical guidance and a comprehensive therapeutic overview regarding the appropriate use of this treatment option.

Eligibility and Restrictions for Use

Eligibility Map: Official Regulatory Information

Synthyroxine (Levothyroxine Sodium) is officially indicated for use in adults and pediatric patients for replacement therapy in hypothyroidism, including congenital or acquired forms, and as an adjunct for thyrotropin-dependent thyroid cancer management. This includes use across the entire pediatric age range, from infants through adolescents.

Use of the medicine is contraindicated in specific populations to prevent serious complications. Patients must not use Synthyroxine if they have uncorrected adrenal insufficiency, as this can precipitate an acute adrenal crisis. It is also contraindicated for patients experiencing acute myocardial infarction or other acute cardiac inflammation, or those with overt thyrotoxicosis.

Regulatory documents explicitly prohibit the use of Synthyroxine for the sole purpose of treating obesity or for weight loss in individuals with normal thyroid function. Additionally, the label requires conditional use for certain groups: therapy in geriatric patients and those with pre-existing cardiovascular disease must be initiated at a lower starting dose due to increased cardiac risk. Treatment is generally permitted during pregnancy and lactation; however, close monitoring and dose adjustments are often necessary for pregnant patients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pharmacokinetic Interactions: Altered Absorption

Co-administration of Synthyroxine (Levothyroxine Sodium) with numerous substances can interfere with its gastrointestinal absorption, resulting in decreased systemic exposure. This includes cation-containing products such as iron preparations (ferrous sulfate) and calcium carbonate, which can form complexes with Levothyroxine. Bile acid sequestrants (e.g., cholestyramine) and the anti-ulcer agent sucralfate also bind the hormone, reducing its uptake. Proton pump inhibitors and other acid suppressants may also reduce absorption by increasing gastric pH.

Mandatory Administration Separation

To mitigate reduced absorption, regulatory guidelines require mandatory time separation. Levothyroxine must be administered at least four hours apart from antacids, calcium, iron supplements, and bile acid sequestrants. A separation window of at least five hours is required for sucralfate.

Pharmacodynamic and Metabolic Interactions

Oral anticoagulants (e.g., warfarin) can have their effect potentiated by Levothyroxine, potentially increasing the risk of bleeding. Enzyme inducers, including certain anticonvulsants (phenytoin, carbamazepine) and antibiotics (rifampicin), increase the clearance of T4, which may lower plasma concentrations. Estrogen therapy and oral contraceptives increase thyroxine-binding globulin, reducing free T4 levels.

Dietary Considerations

Food, particularly high-fiber meals, reduces the extent of Levothyroxine absorption. Additionally, soy products are officially documented to interfere with Levothyroxine absorption, primarily noted as a caution in infants receiving soy-based formula.

Mechanism of Action

How Synthyroxine works

Synthyroxine, a synthetic version of thyroxine (T4), is initially an inactive precursor that requires enzymatic conversion within the body's tissues. Deiodinase enzymes perform this crucial step, transforming the T4 into the active hormone, triiodothyronine (T3) . The activation mechanism facilitates the continuous availability of the signaling molecule required for subsequent mechanistic steps.

The active T3 hormone functions as a nuclear receptor agonist, traveling into the cell nucleus and binding to Thyroid Hormone Receptors (TRs) located on the DNA. This binding directly regulates the transcription of numerous target genes, governing the synthesis of key proteins that dictate cellular function. This mechanism is responsible for modifying the fundamental programming of cells across multiple body systems.

By restoring this genetic signaling, the drug normalizes the activity of pathways that control energy use and consumption. This mechanistic domain influences the basal metabolic rate (BMR) and affects the expression of proteins that modulate cardiac output and the body's sensitivity to other hormones, such as catecholamines. This domain is critical for the resulting modulation of the body's thermoregulation and energy balance at the systemic level.

Dosage and Administration Information

Synthyroxine (Levothyroxine Sodium) is administered primarily via the oral route for long-term replacement therapy. The medication is dosed once daily, typically following a weight-based calculation where the average full replacement dose for a healthy adult is approximately 1.6 micrograms per kilogram per day. Therapy requires a precise titration schedule: dose adjustments, made in 12.5 to 25 microgram increments, occur only every four to six weeks because the full therapeutic effect of any change may not be fully attained until weeks later.

Proper administration is critically dependent on timing and food relationship. The medication must be taken on an empty stomach, specifically one-half to one hour before breakfast, to ensure optimal and consistent absorption. Furthermore, to prevent reduced efficacy, patients must adhere to the rule of administering the dose at least four hours before or after any substances that interfere with absorption, such as antacids, iron, or calcium supplements.

Official guidance outlines population-specific adjustments. For older adults or patients with established cardiovascular disease, the starting dose is significantly lower—often 12.5 to 25 micrograms per day—and the subsequent titration interval is slower, extended to six to eight weeks. While the oral form is standard, the intravenous (IV) route is reserved for the treatment of severe, acute conditions like Myxedema Coma or when patients cannot tolerate oral intake, requiring specific reconstitution with 0.9% Sodium Chloride Injection. If a dose is missed, patients should take it as soon as remembered that day, but must not double the dose the following day.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Synthyroxine

The research evidence for Synthyroxine (Levothyroxine Sodium) focuses on its primary role as replacement therapy and its adjunctive use in cancer management. This overview summarizes the scope and limitations of the available studies.


Evidence for Use as Replacement Therapy in Hypothyroidism

Evidence for this core indication relies on long-term observational cohorts and regulatory bioequivalence studies that assess the similar absorption and utilization of various formulations. Research explores shifts in biomarkers like TSH and FT4 levels, along with patient-reported outcomes describing physical discomfort. Studies describe patterns related to the normalization of these hormone levels. Limitations primarily relate to the critical need for precise individual dose adjustment and ongoing exploration of whether universal restoration of systemic balance is achieved in all individuals.


Evidence for Use as Adjuvant Therapy in Thyroid Cancer

Synthyroxine was studied for its use after surgery for differentiated thyroid cancer, where the goal is TSH suppression. Long-term observational studies monitored populations of Adults and Adolescents, tracking outcomes such as cancer recurrence and Disease-Free Survival. While data show patterns related to tracking survival and recurrence over periods extending beyond five years, subgroup findings are uncertain regarding optimal TSH target ranges. The long-term effects of the required higher dosing on physiological strain or stress in the heart and bones are not fully established.


Evidence in Special Populations

Research involving pregnant women with subclinical hypothyroidism is characterized by mixed findings, leading to an overall Low to Moderate evidence rating. Randomized Controlled Trials (RCTs) explored effects on obstetrical and neonatal outcomes. However, data for certain groups remain insufficient to conclusively determine the influence of treatment on long-term childhood neurodevelopmental outcomes, and certainty remains low regarding whether treatment is necessary for all individuals diagnosed.


Evidence Gaps and Areas of Scientific Uncertainty

Follow-up durations were limited for fully characterizing all long-term effects across all indications. Evidence quality varies across studies, particularly for subclinical hypothyroidism. The field continues to explore the variability in patient response; findings describe group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Thyroid disease: assessment and management – NICE Guideline NG145
  2. Thyroid Stimulating Hormone (TSH) Suppression – ThyCa Guidelines Overview
  3. Effect of Levothyroxine on Older Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis

Frequently Asked Questions (FAQ)

Common questions about Synthyroxine (FAQ)


Q: Is Synthyroxine the same as other thyroid hormone replacement drugs?

A: Synthyroxine contains Levothyroxine (T4), which is a synthetic version of the primary hormone produced by the thyroid gland. According to official documents, it is designed to be biologically identical to natural T4. Other replacement options may exist, such as those that include both synthetic T4 and T3, or those derived from animal thyroid glands.


Q: How is Synthyroxine different from natural desiccated thyroid extract?

A: Synthyroxine is a synthetic, standardized product that contains only the T4 hormone. In contrast, desiccated thyroid extracts (DTE) are derived from animal glands and contain both T4 and T3 hormones. Regulatory bodies may emphasize that synthetic products offer a standardized formulation, which is considered important for hormone therapy precision, compared to extracts.


Q: Is it safe to take Synthyroxine during pregnancy?

A: Official labeling and authoritative sources indicate that Levothyroxine use during pregnancy is generally considered acceptable. Untreated or poorly managed hypothyroidism during pregnancy is linked to risks for both the mother and the developing fetus. Discontinuing treatment without professional guidance is generally discouraged by official sources. Close monitoring of hormone levels is typically necessary.


Q: Does Synthyroxine pass into breast milk if I am breastfeeding?

A: Levothyroxine is a normal component of human milk, and authoritative databases suggest that the amount passed through breast milk while on replacement doses has not been shown to cause harm to nursing infants. The use of any medication during lactation involves discussion with a healthcare provider.


Q: What are the signs that my Synthyroxine dose might be too low?

A: If the dose is insufficient, official documents suggest that the persistence or return of hypothyroid symptoms may occur. These can include symptoms such as increased fatigue, weight gain, feeling cold, or having dry skin. These signs may suggest the need for further assessment to determine if a dose adjustment is appropriate.


Q: Does alcohol consumption affect Synthyroxine?

A: Regulatory guidance primarily emphasizes the importance of separating the dose from absorption-interfering substances, which typically involves foods and certain supplements. While alcohol is not explicitly listed as a mandatory separation agent, the potential effect of consuming alcohol near the time of dosing is typically reviewed by a healthcare professional.


Q: How often do people usually need to get blood tests while taking Synthyroxine?

A: Monitoring is required to ensure the dose is correct. Initial monitoring of Thyroid Stimulating Hormone (TSH) is typically performed every 6 to 8 weeks until a stable level is achieved. Once the level is stable, professional guidelines often suggest reducing the review frequency to every six months or annually.


Q: Are there generic versions of Synthyroxine available?

A: Yes. Synthyroxine is a brand name for the active ingredient, Levothyroxine Sodium. The active ingredient is also available in generic versions that have been approved by regulatory bodies, typically following a rigorous approval process.


Q: Why do different brands of the same drug sometimes exist?

A: Different brands exist because various drug manufacturers can obtain regulatory approval to market their own versions of the same active ingredient. These versions are approved through a process that verifies their bioequivalence to the reference product.


Q: Is hair loss a reported side effect of Synthyroxine?

A: Official product labeling notes that hair loss has been reported with Levothyroxine products. This is often observed in the early stages of treatment or when the dose is either too high or too low. The issue is often observed to lessen or resolve once the thyroid hormone levels are stabilized.


Q: Can Synthyroxine be split or crushed if I have trouble swallowing pills?

A: The official label for some Levothyroxine formulations does permit crushing the tablet and mixing the resulting powder with a small amount of water for immediate administration. Patients are advised to refer to the specific product instructions and consult their dispensing pharmacist.


Q: How does the body typically eliminate Synthyroxine?

A: Levothyroxine has a relatively long half-life of approximately 6 to 7 days, meaning it takes a long time for the body to process and clear the hormone. Based on this, it can take approximately 4 to 6 weeks for the drug to be eliminated from the body after discontinuation.


Q: Is it necessary to inform dentists or other specialists that I take Synthyroxine?

A: Yes. Official safety labeling states that patients should tell any doctor who treats them that they are using this medicine. This is particularly important for any planned surgery or dental procedures to ensure all aspects of care are coordinated.


Q: Why is it important to use the same brand of Synthyroxine consistently?

A: Levothyroxine is considered a narrow therapeutic index drug, meaning even small differences in how the body absorbs different formulations can impact treatment effectiveness. Due to this sensitivity, clinical guidelines suggest that continued use of the same specific product (same brand or same generic manufacturer) may help maintain consistent hormone levels.


Q: Is it possible to be allergic to ingredients in Synthyroxine?

A: Yes. Regulatory documents contraindicate the use of this medicine if a patient is known to be allergic to the active ingredient (Levothyroxine) or any of the inactive ingredients (excipients), such as color additives or other components used in the tablet formulation.


Q: Does Synthyroxine interact with common pain relievers like ibuprofen or acetaminophen?

A: Most non-prescription pain relievers, such as acetaminophen and ibuprofen, are not typically listed as having a direct pharmacological interaction with Levothyroxine in regulatory documents. However, all medications, including over-the-counter products, should be reviewed by a healthcare provider for any potential effects.

How should Synthyroxine be stored and disposed of?

How to Store and Dispose of Levothyroxine Sodium (Synthyroxine)

Official regulatory documents define strict conditions for storing Levothyroxine Sodium tablets to ensure product stability and potency. The medication must be kept at controlled room temperature, generally between 15 C to 30 C (59 F to 86 F).

The tablets are sensitive and must be protected from light, moisture, and heat. To maintain these conditions, the product should remain in its original container and be kept tightly closed.

All medicinal products must be stored out of the reach of children.

Disposal Requirements

Disposal of any unused or expired product must be done according to local requirements and guidance from a healthcare professional or pharmacist. It is mandated not to dispose of this medicine by flushing it down a toilet or pouring it into a drain unless specific instructions permit this.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Synthyroxine found in:

A-Z Index: